Showing results (141-150 of 320) with videos related to

Sort By:
Pageof 32
Human Molecular Genetics|July 23, 2003
Reactivation of the silenced and imprinted alleles of ARHI is associated with increased histone H3 acetylation and decreased histone H3 lysine 9 methylationSatoshi Fujii, Robert Z Luo, Jiuhong Yuan, et al.
Leukemia & Lymphoma|May 3, 2008
Prognostic value of serum soluble interleukin-2 receptor level in patients with diffuse large B cell lymphoma, treated with CHOP- or RCHOP-based therapyYasuhiro Oki, Harumi Kato, Keitaro Matsuo, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 8, 2011
Interstitial pneumonia after autologous hematopoietic stem cell transplantation in B-cell non-hodgkin lymphomaHarumi Kato, Kazuhito Yamamoto, Hirofumi Taji, et al.
Molecular Cancer Therapeutics|December 17, 2016
Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer EpigenomeNoël J-M Raynal, Elodie M Da Costa, Justin T Lee, et al.
Clinical Epigenetics|July 24, 2019
Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemiaWoonbok Chung, Andrew D Kelly, Patricia Kropf, et al.
European Journal of Haematology|February 13, 2010
Primary gastric diffuse large B-cell Lymphoma (DLBCL): analyses of prognostic factors and value of pretreatment FDG-PET scanDai Chihara, Yasuhiro Oki, Shouji Ine, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 16, 2007
Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancerLanlan Shen, Minoru Toyota, Yutaka Kondo, et al.
Blood|November 8, 2003
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in hematopoietic malignanciesJean-Pierre J Issa, Guillermo Garcia-Manero, Francis J Giles, et al.
Plos One|August 23, 2011
Mechanisms of resistance to decitabine in the myelodysplastic syndromeTaichun Qin, Ryan Castoro, Samih El Ahdab, et al.
Epigenetics|March 8, 2012
Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemiaJumpei Yamazaki, Rodolphe Taby, Aparna Vasanthakumar, et al.
Pageof 32